Does AZITHROMYCIN ANHYDROUS Cause Product use in unapproved indication? 639 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 639 reports of Product use in unapproved indication have been filed in association with AZITHROMYCIN ANHYDROUS. This represents 4.4% of all adverse event reports for AZITHROMYCIN ANHYDROUS.
639
Reports of Product use in unapproved indication with AZITHROMYCIN ANHYDROUS
4.4%
of all AZITHROMYCIN ANHYDROUS reports
103
Deaths
229
Hospitalizations
How Dangerous Is Product use in unapproved indication From AZITHROMYCIN ANHYDROUS?
Of the 639 reports, 103 (16.1%) resulted in death, 229 (35.8%) required hospitalization, and 36 (5.6%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZITHROMYCIN ANHYDROUS. However, 639 reports have been filed with the FAERS database.
What Other Side Effects Does AZITHROMYCIN ANHYDROUS Cause?
Off label use (3,288)
Drug ineffective (1,587)
Drug hypersensitivity (1,355)
Dyspnoea (947)
Nausea (727)
Diarrhoea (696)
Asthma (668)
Condition aggravated (621)
Cough (580)
Electrocardiogram qt prolonged (510)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which AZITHROMYCIN ANHYDROUS Alternatives Have Lower Product use in unapproved indication Risk?
AZITHROMYCIN ANHYDROUS vs AZITHROMYCIN OR METHOTREXATE
AZITHROMYCIN ANHYDROUS vs AZOSEMIDE
AZITHROMYCIN ANHYDROUS vs AZTREONAM
AZITHROMYCIN ANHYDROUS vs AZTREONAM LYSINE
AZITHROMYCIN ANHYDROUS vs BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN